Pharmaceutical manufacturer Curis Lifesciences will debut on the NSE SME platform on Friday, November 14 after an overwhelming response from investors and a modest gray market premium (GMP) ahead of the listing. The GMP stands at Rs 9 per share, or around 7% above the issue price of Rs 128, suggesting the stock could trade […]
